Interne geneeskunde met aandachtsgebied Oncologie (de studie en behandeling van kanker)
Polikliniek Interne Geneeskunde
Afdeling A 05, rode route
Telefoonnummer: (020) 755 7022

Publicaties

Analysis of deoxycytidine accumulation in gemcitabine treated patients. Nucleosides Nucleotides Nucleic Acids. 2006; 25 (9): 1225-32.
Honeywell R, van Groeningen CJ, Laan AC, Strocchi E, Ruiter R, Giaccone G, Peters GJ.

The determination of gemcitabine and 2'-deoxycytidine in human plasma and tissue by APCI tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Oct 20.
Honeywell R, van Groeningen CJ, Laan AC, Strocchi E, Ruiter R, Giaccone G, Peters GJ.

Iron absorption during epoetin alfa therapy for chemotherapy-associated anaemia. Cancer invest. 2006 Oct; 24(6):562-6.
Savonije JH, van Groeningen CJ, van den Broek WJ, Rentinck ME Corstens FH, Gundy C, Giaccone G, Marx JJ.

Phase I trial with BMX-275183, a novel oral taxane with promising antitumor activity. Clin Cancer Res. 2006 Mar 15;12(6):1760-7
Broker LE, de Vos FY van Groeningen CJ, Kuenen BC, Gall HE, Woo MH, VOI M, Gietema JA, de Vries EG, Giaccone G.

Pharmacology of the paclitaxelcisplatin, gemcitabine-cisplatin, and paclitaxel-gemcitabine combiantions in patients with advanced non-small cell lung cancer. Cancer Chemother Pharmacol. 2006 Oct;58(4);509-16
Krope Jr, Smit Ef, Giaccone G, Van der Born K, Beijnen JH, Van Groeningen CJ, Van der vijgh WJ Postmus PE, Pinedo HM, Peters GJ.

Early intervention with epoetin alfa during platinum-based chemotherapy: an analysis of the results of a multicenter, randomized, controlled trial based on initial hemoglobin level. Oncologist. 200 Feb;11(2):206-16
Savonije JH, van Groeningen CJ, Wormhoudt LW, Giaccone G.

Early Intervention with epoetin alfa during platinum-based chemotherapy: an analysis of quality-of-life results of a multicenter, randomized, controlled trial compared with population normative data. Oncologis. 2006 Feb; 11(2):197-205
Savonije JH, van Groeningen CJ, Wormhoudt LW, Giaccone G.

EORTC Genito-Urinary Cancer Group. Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours. Eur J Cancer. 2006 Jan;42(1):50-4
Sternberg CN, de Mulder P, Schornagel JH, Theodore C, Fossa SD, van Oosterom AT, Witjes JA, Spina M, van Groeningen CJ, Duclos B, Roberts JT, de Balincourt C, Collette L.

No evidence of gemcitabine accumulation during weekly administration. Eur J Clin Pharmacol. 2005 Dec;61(11):843-9
de lange SM, van der Born K, Kroep JR, Jensen HA PFeiffer P, Cleverly A,  van Groeningen CJ, Peters GJ.

Phase II study of tailored chemotherapy for advanced colorectal cancer with either 5-fluouracil and leucovorin or oxaliplatin and irinotecan based on the expression of thymidylate synthase and dihydropyrimidine dehydrogenase. Ann Oncol. 2006 Jan;17(1):35-42.
Smorenburg CH, Peters GJ, van Groeningen CJ, Nordhuis P, Smid K, van Riel AM, Dercksen W, Pinedo HM Giaccone G.

A phaw I study of monohydroxyethylrutoside in healthy volunteers. Cancer Chemother Pharmacol. 2006 May;57(5):678-84.
Willems AM, Bruynzeel AM, Kedde MA, van Groeningen CJ, Bast A, van der Vijgh WJ.

Pharmacokinetics of bolus 5-fluorouracil: relationship between dose, plasma concentrations, area-under-the-curve and toxicity. J. Chemother. 2005 Jun;17(3):315-20
Codacci-Pisanelli G, Pinedo HM, Lankelma J, Van Groeningen CJ, Van Kuilenburg AB, Van Gennip AH, Peters GJ.

Effects of early intervention with epoetin alfa on transfusion requirement, hemoglobin level and survival during plantinum-based chemotherapy: Results of a multicenter randomised controlled trial. Eur J. Cancer. 2005 Jul;41(11):1560-9.
Savonije JH, van Groeningen CJ, van Bochove A, Honkoop AH, van Felius CL, Wormhoudt LW, Giaccone G.

Interne geneeskunde